Table 1 Demographic and baseline characteristics of suspected COVID-19 patients
Characteristic | All | COVID-19 | Not COVID-19 | p value | |
|---|---|---|---|---|---|
Overall | 100 | 42 | 58 | ||
Age (years) | N | 100 | 42 | 58 | |
Mean (SD) | 45 (19) | 52 (16) | 39 (19) | ||
Median (range) | 42.5 (4, 89) | 56.5 (24, 89) | 31.5 (4, 88) | < 0.001 | |
Age group (years) | 1–5 | 1 (1) | 0 (0) | 1 (2) | 0.003 |
6-12 | 0 (0) | 0 (0) | 0 (0) | ||
13-18 | 1 (1) | 0 (0) | 1 (2) | ||
19-40 | 47 (47) | 12 (29) | 35 (60) | ||
41-59 | 25 (25) | 13 (31) | 12 (21) | ||
60 + | 26 (26) | 17 (40) | 9 (16) | ||
Sex | Female | 42 (42) | 19 (45) | 23 (40) | 0.682 |
Male | 58 (58) | 23 (55) | 35 (60) | ||
Nationality | American | 2 (2) | 0 (0) | 2 (3) | 0.024 |
Chinese | 14 (14) | 2 (5) | 12 (21) | ||
Filipino | 83 (83) | 40 (95) | 43 (74) | ||
German | 1 (1) | 0 (0) | 1 (2) | ||
Health worker | No | 89 (89) | 39 (93) | 50 (86) | 0.350 |
Yes | 11 (11) | 3 (7) | 8 (14) | ||
Recent international travel history (within 14 days prior to admission) | No | 53 (53) | 31 (74) | 22 (38) | < 0.001 |
China | 19 (19) | 3 (7) | 16 (28) | ||
other Asia | 24 (24) | 5 (12) | 19 (33) | ||
Europe or USA | 3 (3) | 2 (5) | 1 (2) | ||
United Arab Emirates | 1 (1) | 1 (2) | 0 (0) | ||
Reported symptoms | |||||
Coryza | No | 59 (59) | 24 (57) | 35 (60) | 0.838 |
Yes | 41 (41) | 18 (43) | 23 (40) | ||
Cough | No | 30 (30) | 10 (24) | 20 (34) | 0.277 |
Yes | 70 (70) | 32 (76) | 38 (66) | ||
Fever | No | 61 (61) | 24 (57) | 37 (64) | 0.538 |
Yes | 39 (39) | 18 (43) | 21 (36) | ||
Sore throat | No | 79 (79) | 30 (71) | 49 (84) | 0.139 |
Yes | 21 (21) | 12 (29) | 9 (16) | ||
Difficulty breathing | No | 82 (82) | 30 (71) | 52 (90) | 0.033 |
Yes | 18 (18) | 12 (29) | 6 (10) | ||
Other symptoms | No | 94 (94) | 39 (93) | 55 (95) | 0.694 |
Yes | 6 (6) | 3 (7) | 3 (5) | ||
Co-morbidities | |||||
Cardiovascular disease | No | 93 (93) | 38 (90) | 55 (95) | 0.449 |
Yes | 7 (7) | 4 (10) | 3 (5) | ||
Diabetes | No | 91 (91) | 35 (83) | 56 (97) | 0.033 |
Yes | 9 (9) | 7 (17) | 2 (3) | ||
Hypertension | No | 77 (77) | 28 (67) | 49 (84) | 0.053 |
Yes | 23 (23) | 14 (33) | 9 (16) | ||
Respiratory illness, including asthma | No | 90 (90) | 35 (83) | 55 (95) | 0.090 |
Yes | 10 (10) | 7 (17) | 3 (5) | ||
HIV | Unknown | 99 (99) | 42 (100) | 57 (98) | - |
Yes | 1 (1) | 0 (0) | 1 (2) | ||
At least one underlying disease | No | 69 (69) | 22 (52) | 47 (81) | 0.004 |
Yes | 31 (31) | 20 (48) | 11 (19) | ||
Pregnancy in women | 1/41 (3%) | 0/19 (0%) | 1/22 (4%) | - | |
Duration between onset of symptoms and admission | N | 97 | 39 | 58 | |
mean (SD) | 6 (6) | 8 (5) | 5 (6) | ||
median (range) | 4 (0, 29) | 7 (0, 19) | 3 (0, 29) | < 0.001 | |